Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Potential Role for STAT3 Inhibitors in Glioblastoma NEUROSURGERY CLINICS OF NORTH AMERICA Jackson, C., Ruzevick, J., Amin, A. G., Lim, M. 2012; 23 (3): 379-+

Abstract

Glioblastoma multiforme (GBM) is the most common and aggressive primary brain tumor. Signal transducers and activators of transcription 3 (STAT3) is a transcription factor that translocates to the nucleus to modulate the expression of a variety of genes associated with cell survival, differentiation, proliferation, angiogenesis, and immune function. Several cancers induce constitutive STAT3 activation. Most studies have reported that STAT3 inhibition has antineoplastic activity; however, emerging evidence suggests that the role of STAT3 activity in GBM may be more nuanced than initially appreciated. The authors review the roles of STAT3 in GBM and discuss potential strategies for targeting STAT3.

View details for DOI 10.1016/j.nec.2012.04.002

View details for Web of Science ID 000307024800004

View details for PubMedID 22748651